Virbac Future Growth

Future criteria checks 1/6

Virbac is forecast to grow earnings and revenue by 10.7% and 5.9% per annum respectively. EPS is expected to grow by 10.4% per annum. Return on equity is forecast to be 14.2% in 3 years.

Key information

10.7%

Earnings growth rate

10.4%

EPS growth rate

Pharmaceuticals earnings growth	23.6%
Revenue growth rate	5.9%
Future return on equity	14.2%
Analyst coverage	Good
Last updated	16 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:VRBC.F - Analysts future estimates and past financials data (EUR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	1,586	185	145	240	5
12/31/2025	1,502	165	119	209	8
12/31/2024	1,408	151	51	173	9
6/30/2024	1,339	141	74	139	N/A
3/31/2024	1,293	131	66	129	N/A
12/31/2023	1,247	121	59	119	N/A
9/30/2023	1,229	120	69	124	N/A
6/30/2023	1,210	119	78	129	N/A
3/31/2023	1,213	121	62	114	N/A
12/31/2022	1,216	122	45	99	N/A
9/30/2022	1,184	120	38	91	N/A
6/30/2022	1,151	119	31	84	N/A
3/31/2022	1,107	116	57	107	N/A
12/31/2021	1,064	113	83	130	N/A
9/30/2021	1,025	137	80	122	N/A
6/30/2021	985	161	77	113	N/A
3/31/2021	960	148	83	116	N/A
12/31/2020	934	136	90	119	N/A
9/30/2020	944	104	106	133	N/A
6/30/2020	953	72	123	146	N/A
3/31/2020	946	62	116	139	N/A
12/31/2019	938	52	109	132	N/A
9/30/2019	921	43	92	119	N/A
6/30/2019	903	34	76	106	N/A
3/31/2019	886	27	63	95	N/A
12/31/2018	869	20	50	84	N/A
9/30/2018	862	8	58	93	N/A
6/30/2018	854	-4	66	103	N/A
3/31/2018	858	-3	N/A	105	N/A
12/31/2017	862	-3	N/A	108	N/A
9/30/2017	871	16	N/A	112	N/A
6/30/2017	879	35	N/A	117	N/A
3/31/2017	876	35	N/A	130	N/A
12/31/2016	872	35	N/A	142	N/A
9/30/2016	861	30	N/A	119	N/A
6/30/2016	850	26	N/A	95	N/A
3/31/2016	851	18	N/A	71	N/A
12/31/2015	853	9	N/A	46	N/A
9/30/2015	846	21	N/A	59	N/A
6/30/2015	839	32	N/A	72	N/A
3/31/2015	806	48	N/A	74	N/A
12/31/2014	773	64	N/A	76	N/A
9/30/2014	752	60	N/A	77	N/A
6/30/2014	730	56	N/A	78	N/A
3/31/2014	733	58	N/A	76	N/A
12/31/2013	736	61	N/A	74	N/A
9/30/2013	727	61	N/A	68	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VRBC.F's forecast earnings growth (10.7% per year) is above the savings rate (2.5%).

Earnings vs Market: VRBC.F's earnings (10.7% per year) are forecast to grow slower than the US market (15.3% per year).

High Growth Earnings: VRBC.F's earnings are forecast to grow, but not significantly.

Revenue vs Market: VRBC.F's revenue (5.9% per year) is forecast to grow slower than the US market (8.8% per year).

High Growth Revenue: VRBC.F's revenue (5.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: VRBC.F's Return on Equity is forecast to be low in 3 years time (14.2%).

Virbac Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Virbac SA Revises Earnings Guidance for the Fiscal Year 2024

Virbac SA Provides Earnings Guidance for the Year 2024

Virbac SA Confirms Revenue Forecasts for the Year 2023

Virbac SA Provides Revenue Guidance for the Year 2022

Recent updates

Virbac SA Revises Earnings Guidance for the Fiscal Year 2024

Virbac Sa Announces Chief Executive Officer Changes

Virbac Sa Announces Chief Executive Officer Changes

Virbac SA (ENXTPA:VIRP) acquired Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591).

Virbac SA (ENXTPA:VIRP) entered into a definitive agreement to acquire Sasaea Holdings Co., Ltd. from ORIX Corporation (TSE:8591) for an enterprise value of approximately €280 million.

Virbac SA Provides Earnings Guidance for the Year 2024

Virbac SA to Report Fiscal Year 2023 Results on Mar 19, 2024

Virbac SA (ENXTPA:VIRP) signed an agreement to acquire Globion India Private Limited from Suguna Foods Private Limited and Lohmann Animal Health GmbH.